Lupron Depot — Class II drug recall D-1290-2014
Terminated recall by AbbVie Inc, reported 2014-05-07, distributed nationwide. Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc
| Recall number | D-1290-2014 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | AbbVie Inc, North Chicago, IL, United States |
| Recall initiated | 2014-03-10 |
| Classified | 2014-04-29 |
| Reported by FDA | 2014-05-07 |
| Terminated | 2016-06-22 |
| Distributed | Nationwide (US) |
| Quantity | 1,530 kits |
| UPC / GTIN / UDI-DI | 00300743663037 |
| NDC | 00074-3663, 00074-3663-03 |
| Lot numbers | 1013906 |
| Expiration dates | 2016-09-21 |
Product
Lupron Depot (leuprolide acetate for depot suspension) Single Dose Administration Kit with prefilled dual-chamber syringe, 11.25 mg for 3-Month administration, Rx only, Manufactured for: AbbVie Inc., North Chicago, IL 60064; by: Takeda Pharmaceutical Company Limited, Osaka, Japan 540-8645; NDC 0074-3663-03, UPC 3 00743 66303 7.
Reason for recall
Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1290-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.